ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,070.97
0.16%
US Tech 100
21,106.84
0.16%
다우존스 지수
44,776.81
-0.21%
Bitcoin
97,225.27
0.61%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Inventiva Sa (0RNK) 시세

Inventiva Sa

Inventiva Sa (0RNK)

LSE
7.62
0.00
( 0.00% )
업데이트: 09:00:00
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
7.62
매수가
0.00
매도가
0.00
거래량
41
0.00 일간 변동폭 0.00
7.62 52주 범위 7.62
market_cap
397.124M
전일 종가
7.62
개장가
-
최근 거래 시간
41
@
2.35
(O)
마지막 거래 시간
17:35:08
재정 규모
-
VWAP
-
평균 볼륨(3m)
274
발행 주식
52,116,000
배당수익률
-
주가수익률
-1.10
주당순이익(EPS)
-2.12
매출
23.16M
순이익
-110.43M

Inventiva Sa 정보

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.inventivapharma.com
본부
Daix, Fra
설립됨
-
Inventiva Sa is listed in the Biological Pds,ex Diagnstics sector of the 런던증권거래소 with ticker 0RNK. The last closing price for Inventiva was 7.62 €. Over the last year, Inventiva shares have traded in a share price range of 7.62 € to 7.62 €.

Inventiva currently has 52,116,000 shares in issue. The market capitalisation of Inventiva is 397.12 € million. Inventiva has a price to earnings ratio (PE ratio) of -1.10.

0RNK 최신 뉴스

추가 뉴스

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of...

30 1월 2025
UK Regulatory

Inventiva annonce la publication dans la revue « Journal of Hepatology » des résultats de l’étude clinique de preuve de concept initiée par un investigateur évaluant lanifibranor chez des patients atteints de DT2 et MASLD

Inventiva annonce la publication dans la revue « Journal of Hepatology » des résultats de l’étude clinique de preuve de concept initiée par un investigateur évaluant lanifibranor chez des patients...

30 1월 2025
UK Regulatory

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux Daix (France), New York City (New York, United States), January 24, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA...

25 1월 2025
UK Regulatory

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux Daix (France), New York City (New York, Etats-Unis), le 24 janvier 2025 – Inventiva (Euronext Paris...

25 1월 2025
UK Regulatory

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025 Daix (France), New York City (New York...

23 1월 2025
UK Regulatory

Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025

Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025 Daix (France), New York City (New...

23 1월 2025
UK Regulatory

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA...

18 12월 2024
UK Regulatory

Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference »

Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference » Daix (France), New York City (New York, Etats Unis), le 17 décembre 2024 – Inventiva (Euronext Paris and...

18 12월 2024
UK Regulatory

Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million

Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million Inventiva secures €21.4 million leading to completion of...

16 12월 2024
UK Regulatory

Inventiva obtient 21,4 millions d'euros complétant la première tranche du financement multi-tranches annoncé précédemment d'un montant maximum de 348 millions d'euros

Inventiva obtient 21,4 millions d'euros complétant la première tranche du financement multi-tranches annoncé précédemment d'un montant maximum de 348 millions d'euros Inventiva lève...

16 12월 2024
UK Regulatory
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1007.627.627.621107.62DE
4007.627.627.625587.62DE
12007.627.627.622747.62DE
26007.627.627.627517.62DE
52007.627.627.625247.62DE
156007.627.627.6219167.62DE
260007.627.627.6229787.62DE

0RNK - Frequently Asked Questions (FAQ)

What is the current Inventiva share price?
The current share price of Inventiva is 7.62 €
How many Inventiva shares are in issue?
Inventiva has 52,116,000 shares in issue
What is the market cap of Inventiva?
The market capitalisation of Inventiva is EUR 397.12M
What is the 1 year trading range for Inventiva share price?
Inventiva has traded in the range of 7.62 € to 7.62 € during the past year
What is the PE ratio of Inventiva?
The price to earnings ratio of Inventiva is -1.1
What is the cash to sales ratio of Inventiva?
The cash to sales ratio of Inventiva is 5.26
What is the reporting currency for Inventiva?
Inventiva reports financial results in EUR
What is the latest annual turnover for Inventiva?
The latest annual turnover of Inventiva is EUR 23.16M
What is the latest annual profit for Inventiva?
The latest annual profit of Inventiva is EUR -110.43M
What is the registered address of Inventiva?
The registered address for Inventiva is 50 RUE DE DIJON, DAIX, 21121
What is the Inventiva website address?
The website address for Inventiva is www.inventivapharma.com
Which industry sector does Inventiva operate in?
Inventiva operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ORCPOracle Power Plc
0.0205p
(31.41%)
2.37B
NOGNostrum Oil & Gas Plc
3.50p
(25.00%)
4.22k
NTQEnteq Technologies Plc
1.60p
(23.08%)
1.33M
FXPOFerrexpo Plc
90.00p
(22.28%)
6.33M
BBGIBbgi Global Infrastructure S.a.
143.40p
(17.73%)
41.46M
RAIRa International Group Plc
0.85p
(-86.92%)
35.88M
TRACT42 Iot Tracking Solutions Plc
2.25p
(-25.00%)
251.1k
W7LWarpaint London Plc
430.00p
(-19.17%)
2.12M
VELAVela Technologies Plc
0.005p
(-16.67%)
77.36M
IMMImmupharma Plc
3.76p
(-16.63%)
11.03M
ORCPOracle Power Plc
0.0205p
(31.41%)
2.37B
NTVONativo Resources Plc
0.0017p
(0.00%)
729.48M
SYMESupply@me Capital Plc
0.0025p
(-9.09%)
656.44M
CPAICapai Plc
0.044p
(0.00%)
229.15M
GFINGfinity Plc
0.09p
(-9.09%)
208.31M

토론

전체 피드 보기
dinogreeves dinogreeves 2 분 전
Amazon scheduled to report today, lets see what they say about AI.
SMCI
chilar4567 chilar4567 2 분 전
Seller says " here's to your good news PR, up yours"
$2.700.00 (0.00%)
Bid x Size
$2.69 x 700
Ask x Size
$2.71 x 1,900
Real Time Equity Quote: Feb 6, 2025, 10:26 AM ETinfo_outline
PAYS
trunkmonk trunkmonk 2 분 전
Since you have that kind of background, its been a while since I used SHO list for trading, is that valuable?
I remember naked trading was rampant and thus they setup SHO lists for stocks. I just dont trade like i used to and dont know how valuable it is cause i dont look at it anymore. some
FNMA
lighter than AIR lighter than AIR 2 분 전
The MMs are not going out of their way to hold this in the 60’s…there has been a lot of dumping, and that’s it…once again you prove you are clueless. And you have said several times this is the result of an eatate selling their shares…once again, just guess work, now that someone sold a big chunk
CBRF
Jackxkr Jackxkr 2 분 전
Why do you think this?
NWBO
Renee Renee 3 분 전
NXSI: effective Feb. 7,2025: inactive security. FINRA will delete the symbol.

https://otce.finra.org/otce/dailyList?viewType=Deletions
NXSI
wagner wagner 3 분 전
CRML dropped hard.... Seems no Greenland buisness on the horizon

Let's build it in America 
NB
ron51ron51 ron51ron51 3 분 전
there are two hypotheses;
1) the CEO is a thief we will sink
2) otherwise it will skyrocket
.... the choice is yours
GRST
Triple nickle Triple nickle 3 분 전
LTRY back at it 1.01
LTRY
MomsSpaghetti MomsSpaghetti 3 분 전
Is this seriously at 43% Short Interest with sub 1M shares outstanding? Talk about squeeze potential. I took a chunk of this!
PBM
Gamco Gamco 3 분 전
Oreeno $211. EOM
IDCC
DiscoverGold DiscoverGold 4 분 전
Money managers Increased their exposure to the US Equity markets since last week...
studentaid.gov/universal-navigation/assets/us_flag_small.png DiscoverGold

NAAIM Exposure Index

February 6, 2025 www.naaim.org/wp-content/themes/naaim/favicon.ico
Shawking Shawking 4 분 전
https://mailchi.mp/lexariabioscience.com/lexaria-biodistribution-study-for-dehydratech-glp-1-is-underway?e=aa4bd7bcad
LEXX
georgie18 georgie18 4 분 전
BBAI...$7.43...Starting up again off the $6.90 dip...🥳
BBAI
georgie18 georgie18 4 분 전
BBAI...$7.43...Starting up again off the $6.90 dip...🥳
BBAI
fredscott36 fredscott36 4 분 전
...........WEAK, little big horn bob...............no game at all............a rematch at LBH and you'd get crushed.............vietnam, same story.........swell the onion and throw down some shade, little big...........................for once........those two numbers are troll nonsense......drivel
Gamco Gamco 4 분 전
Oreeno $210. EOM
IDCC
georgie18 georgie18 4 분 전
BBAI...$7.43...Starting up again off the $6.90 dip...🥳
BBAI
Tiger Money Tiger Money 4 분 전
Heck yes!
RNAZ
RickNagra RickNagra 4 분 전
Oh wow.  I am expecting a massive pop today.
DBMM
Renee Renee 4 분 전
ECORF: effective Feb. 7,2025 a one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
ECORF
prototype_101 prototype_101 5 분 전
tcubed, sent your message to Lebby, he STILL believes EO Polymers will become ubiquitous even after his departure, please note his message to shareholders below was generic to EO Polymers as obviously he cannot speak about LWLG Polymers specifically any longer

wow thank you - I am hon
LWLG
georgie18 georgie18 5 분 전
BBAI...$7.43...Starting up again off the $6.90 dip...🥳
BBAI
NebraskaOTC NebraskaOTC 5 분 전
Good ol' $RDAR
Beginning? :-D
Come onnnnn.... you seem to have SOME common sense. The "deceptive" signs are GLARING!
No worries though.... Al Pacino and his puppy will be in here soon to tell us how great $RDAR is... so they can offload their last bit of shares.
RDAR
hedge_fun hedge_fun 5 분 전
Carnivore is buying QBTS today…..
QBTS

최근 히스토리

LSE
0RNK
Inventiva
LSE
PAT
Panthera Resources
TSX
CSH.UN
Chartwell Retirement Res...
FX
RUBCNY
RUB vs CNY
BOV
BFTA39
First Trust Technology A...
BOV
AMFO4L
Agropecuaria Mf Oliveira... PN
AQSE
BATT.GB
L&G Battery ValueChain U...
BIT
F34862
Vontobel Financial Produ...
BOV
VCJR11
Vectis Juros Real Fundo ...
BOV
LREN3
LOJAS RENNER ON
BOV
CBEE9
AMPLA ENERG ON
BIT
ESIGM
Esi
LSE
GFAM
Granite Gafam
BOV
C1HK34
Check Point Software Tec...
HITB
COVETH
Covesting
BOV
IRBR3R
IRB BRASIL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지